secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunoGen, Inc. (—)
CIK:        0000855654
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001558370-23-015834
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunoGen appoints Lauren White as SVP and CFO effective Sept. 18, 2023
-----------------------------------------------------------------------

- White previously served as CFO of C4 Therapeutics and VP at Novartis, with over 20 years experience.
- Annual salary of $500,000 with bonus eligibility up to 40% of base salary.
- Granted option for 295,975 shares and 51,625 RSUs under 2019 Inducement Plan.
- Renee Lentini steps down as principal financial officer but remains principal accounting officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/855654/000155837023015834/0001558370-23-015834-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/855654/000155837023015834/imgn-20230918x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015834

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer